Subscribe Now Subscribe Today
Science Alert
 
Blue
   
Curve Top
International Journal of Pharmacology
  Year: 2011 | Volume: 7 | Issue: 7 | Page No.: 749-756
DOI: 10.3923/ijp.2011.749.756
 
Facebook Twitter Digg Reddit Linkedin StumbleUpon E-mail

No Superiority of Exenatide over Insulin in Diabetic Patients in Terms of Weight Reduction or Incidence of Adverse Effects: A Meta-analysis

Pooneh Salari, Shekoufeh Nikfar and Mohammad Abdollahi

Abstract:
Recently, exenatide as an incretin mimetic was approved by FDA as an adjunct to diet and exercise in treating type 2 diabetes. Therefore comparing every new medication with insulin can provide more clues about the real benefit of paying extra budget for new drugs. In this meta-analysis we compared the efficacy and tolerability of exenatide to insulin. The literature search provided 1016 articles while only 5 articles were eligible to be included in the meta-analysis with a total of 1404 patients enrolled in the study. The results show that there is no superiority for exenatide over insulin even in its weight reduction advantage. However, the high risk of gastrointestinal side effects including nausea and vomiting is of major concern. Current evidence does not support the advantage of exenatide over insulin but more clinical trials are needed to reach a convincing conclusion.
PDF Fulltext XML References Citation Report Citation
 RELATED ARTICLES:
  •    Quality Assessment for Systematic Review /Meta-Analysis on Antidepressant Therapy Published in Chinese Journals
  •    Concerns on the Use of Chromium in Type 2 Diabetes Mellitus; Needs to Conduct Major Meta-analysis
  •    Antioxidants as an Appropriate Approach to Improve the Outcome of Pancreatic Islet Isolation: Evidences from Animal Studies
  •    It is Time to Formulate an Antioxidant Mixture for Management of Diabetes and its Complications: Notice for Pharmaceutical Industries
  •    A Systematic Review of the Efficacy and Safety of Teucrium Species; from Anti-oxidant to Anti-diabetic Effects
  •    An Update on Pharmacology of Satureja Species; From Antioxidant, Antimicrobial, Antidiabetes and Anti-hyperlipidemic to Reproductive Stimulation
How to cite this article:

Pooneh Salari, Shekoufeh Nikfar and Mohammad Abdollahi, 2011. No Superiority of Exenatide over Insulin in Diabetic Patients in Terms of Weight Reduction or Incidence of Adverse Effects: A Meta-analysis. International Journal of Pharmacology, 7: 749-756.

DOI: 10.3923/ijp.2011.749.756

URL: https://scialert.net/abstract/?doi=ijp.2011.749.756

COMMENT ON THIS PAPER
 
 
 

 

 
 
 
 
 
 
 
 
 

 
 
 
 
 
 
 
 
 
 
 

Curve Bottom